title: Re: Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following a complete hydatidiform mole: a historical database review.
authors.affiliation: Department of Obstetrics and Gynaecology, Umraniye Medical and Research Hospital, İstanbul, Turkey.
authors.forename: Yasemin
authors.initials: Y
authors.lastname: Çekmez
authors.affiliation: Department of Obstetrics and Gynaecology, Umraniye Medical and Research Hospital, İstanbul, Turkey.
authors.forename: Esra Tuştaş
authors.initials: ET
authors.lastname: Haberal
authors.affiliation: Department of Obstetrics and Gynaecology, Umraniye Medical and Research Hospital, İstanbul, Turkey.
authors.forename: İpek
authors.initials: İ
authors.lastname: Ulu
authors.affiliation: Department of Obstetrics and Gynaecology, Umraniye Medical and Research Hospital, İstanbul, Turkey.
authors.forename: Serdar
authors.initials: S
authors.lastname: Gülşen
mesh_terms: D000284:Administration, Oral; D000328:Adult; D015415:Biomarkers / Q000097:blood; D006063:Chorionic Gonadotropin / Q000097:blood*; D003270:Contraceptive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D006828:Hydatidiform Mole / Q000097:blood* / Q000139:chemically induced / Q000628:therapy; D008991:Monitoring, Physiologic; D011247:Pregnancy; D014594:Uterine Neoplasms / Q000097:blood* / Q000139:chemically induced / Q000628:therapy
chemical_list: D015415:Biomarkers; D006063:Chorionic Gonadotropin; D003270:Contraceptive Agents